Fulgent Genetics's market cap is currently $691.46M. The company's EPS TTM is $0.07; its P/E ratio is ―; Fulgent Genetics is scheduled to report earnings on August 1, 2025, and the estimated EPS forecast is $-0.22. See an overview of income statement, balance sheet, and cash flow financials.
